Drug Testing Index Shows Sharp Decline in Employee Drug Use


Illegal drug use among American workers has declined 74% in the 26 years since enactment of the Drug-Free Workplace Act of 1988, according to Quest Diagnostics’ Drug Testing Index (DTI). The national laboratory network bases its index on the results of 125 million employee urine tests performed for employers between 1988 and 2012.

Many see the decline as evidence of the effectiveness of the Drug-Free Workplace Act and of private initiatives to reduce drug use in the workplace. The Act conditions receipt of some federal contracts and all federal grants on the recipients' agreement to maintain drug-free workplaces. Researchers nevertheless advise against complacency, noting that positive tests for marijuana, amphetamines and opiates continue to increase significantly.

Drug use negatively affects the workplace through increased accident and illness rates, higher medical costs, employee turnover and workers’ compensation claims, and lower productivity. Furthermore, potential liability for drug-related industrial accidents, product defects and workplace injuries make it imperative that employers take drug-use prevention seriously.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Thomson Reuters Compliance Learning | Attorney Advertising

Written by:


Thomson Reuters Compliance Learning on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.